BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/12/2023 8:16:26 AM | Browse: 654 | Download: 1510
Publication Name World Journal of Clinical Cases
Manuscript ID 84543
Country Iraq
Received
2023-03-18 17:30
Peer-Review Started
2023-03-18 17:32
First Decision by Editorial Office Director
2023-05-09 08:12
Return for Revision
2023-05-09 08:12
Revised
2023-05-09 19:56
Publication Fee Transferred
Editorial Processing by Scientific Editor
2023-05-15 03:38
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2023-05-15 08:50
Articles in Press
2023-05-15 08:50
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-06-01 01:26
Publish the Manuscript Online
2023-06-12 08:16
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Obstetrics & Gynecology
Manuscript Type Case Control Study
Article Title Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study
Manuscript Source Invited Manuscript
All Author List Eham Amer Ali, Wassan Nori, Alea Farhan Salman, Taghreed S Saeed Al-Rawi, Ban H Hameed and Raid M Al-Ani
ORCID
Author(s) ORCID Number
Eham Amer Ali http://orcid.org/0000-0003-0559-9406
Wassan Nori http://orcid.org/0000-0002-8749-2444
Alea Farhan Salman http://orcid.org/0000-0002-4653-9816
Taghreed S Saeed Al-Rawi http://orcid.org/0000-0001-8321-996
Ban H Hameed http://orcid.org/0000-0001-8451-652X
Raid M Al-Ani http://orcid.org/0000-0003-4263-9630
Funding Agency and Grant Number
Corresponding Author Raid M Al-Ani, MBChB, N/A, Academic Editor, Consultant Physician-Scientist, Full Professor, Researcher, Scientific Editor, Department of Surgery/Otolaryngology, University of Anbar College of Medicine, University of Anbar College of Medicine, Al-Andalus, No. 41 Street, Ramadi City 31001, Anbar, Iraq. med.raed.alani2003@uoanbar.edu.iq
Key Words Early onset preeclampsia; Late-onset preeclampsia; Prediction; Elabela; Preeclampsia; Pregnant women
Core Tip Preeclampsia (PE) is a worldwide cause of increased maternal and perinatal morbidity; PE is divided into early-onset and late-onset subtypes. The precise pathophysiology of PE is obscured, and currently no treatment exists but to terminate pregnancy. Several researches seek a reliable biomarker to anticipate PE to mitigate its negative effects. Elabela (Ela), a recently discovered peptide hormone secreted by the fetus and human placenta; animal studies confirmed Ela’s critical role in maintaining blood pressure; its deficiency was linked to elevated blood pressure. The purpose of this study was to evaluate the accuracy of Ela in predicting PE based on the time of occurrence.
Publish Date 2023-06-12 08:16
Citation Amer Ali E, Nori W, Salman AF, Al-Rawi TSS, Hameed BH, Al-Ani RM. Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study. World J Clin Cases 2023; 11(17): 3993-4002
URL https://www.wjgnet.com/2307-8960/full/v11/i17/3993.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i17.3993
Full Article (PDF) WJCC-11-3993-with-cover.pdf
Full Article (Word) WJCC-11-3993.docx